Key points are not available for this paper at this time.
The discovery of an identical mutation (V617F) of the JAK2 gene in patients with polycythemia vera, essential thrombocythemia, and myelofibrosis — the principal Philadelphia chromosome–negative myeloproliferative disorders — has greatly advanced our understanding of these conditions. This article reviews the legacy of this discovery and how it has changed our view of the origins, interrelations, and management of the myeloproliferative disorders.
Building similarity graph...
Analyzing shared references across papers
Loading...
Peter J. Campbell
Airbus (Italy)
Anthony R. Green
Australian National University
New England Journal of Medicine
University of Cambridge
Building similarity graph...
Analyzing shared references across papers
Loading...
Campbell et al. (Wed,) studied this question.
synapsesocial.com/papers/6a11c0b0e2cb0ccec0c90342 — DOI: https://doi.org/10.1056/nejmra063728